Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May;1(4):169-71.
doi: 10.1159/000443773. Epub 2016 Feb 5.

Successful Treatment of Paecilomyces lilacinus Onychomycosis with Efinaconazole and Tavaborole

Affiliations

Successful Treatment of Paecilomyces lilacinus Onychomycosis with Efinaconazole and Tavaborole

John M Evans et al. Skin Appendage Disord. 2016 May.

Abstract

Paecilomyces lilacinus, also known as Purpureocillium lilacinum, is a non-dermatophyte mold found in the soil and used as nematocide for crops. P. lilacinus can cause rare opportunistic infections in humans ranging from endocarditis, keratitis, to onychomycosis with significant resistance to conventional antifungals. There are only two cases of onychomycosis caused by P. lilacinus reported in the literature and none that were successfully treated. Here we present a case of successfully treated onychomycosis caused by P. lilacinus with efinaconazole and tavaborole in a patient who had failed treatment with oral fluconazole, itraconazole, terbinafine, and topical ciclopirox and naftifine.

Keywords: Efinaconazole; Non-dermatophyte; Onychomycosis; Paecilomyces lilacinus; Purpureocillium lilacinum; Tavaborole; Treatment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Right great toenail P. lilacinus onychomycosis showing distal onycholysis, subungual debris, and yellow discoloration prior to treatment with topical efinaconazole and tavaborole.
Fig. 2
Fig. 2
Right great toenail showing attached distal nail plate without subungual debris or thickened nail bed, status post 4 months treatment with efinaconazole and 2 weeks of tavaborole topical application for P. lilacinus onychomycosis. An incidental non-fungal-related torn nail due to traumatic injury is shown.

References

    1. Luangsa-Ard J, Houbraken J, van Doorn T, Hong SB, Borman AM, Hywel-Jones NL, Samson RA. Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. FEMS Microbiol Lett. 2011;321:141–149. - PubMed
    1. Pastor FJ, Guarro J. Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect. 2006;12:948–960. - PubMed
    1. Fletcher CL, Hay RJ, Midgley G, Moore M. Onychomycosis caused by infection with Paecilomyces lilacinus. Br J Dermatol. 1998;139:1133–1135. - PubMed
    1. Innocenti P, Pagani E, Vigl D, Höpfl R, Huemer HP, Larcher C. Persisting Paecilomyces lilacinus nail infection following pregnancy. Mycoses. 2011;54:e880–e882. - PubMed
    1. Hall VC, Goyal S, Davis MD, Walsh JS. Cutaneous hyalohyphomycosis caused by Paecilomyces lilacinus: report of three cases and review of the literature. Int J Dermatol. 2004;43:648–653. - PubMed

LinkOut - more resources